A striking claim has circulated online — but what did the tesamorelin research actually show?
What is tesamorelin?
Tesamorelin is a stabilized analogue of growth hormone-releasing hormone (GHRH). It is a peptide-based prescription medicine and is biologically very different from cosmetic skincare peptides such as copper peptides.
Why is it being discussed?
A randomized, double-blind, placebo-controlled trial studied adults aged 55–87, including people with mild cognitive impairment and cognitively healthy older adults. Participants received daily tesamorelin or placebo for 20 weeks.
What did the study find?
The trial found a favorable overall effect on cognition, with the clearest signal in executive function. These findings are interesting, but they came from a relatively short clinical trial.
Did it reduce Alzheimer’s risk?
No. The study did not test whether tesamorelin prevents Alzheimer’s disease or reduces a person’s long-term risk of developing Alzheimer’s. It measured cognitive performance over 20 weeks. Improvement on cognitive testing is not the same as demonstrating prevention of Alzheimer’s disease.
What happened in the brain?
A smaller randomized substudy involving 30 participants examined brain chemistry using magnetic resonance spectroscopy. After 20 weeks, researchers observed increases in GABA in several brain regions, an increase in NAAG in the frontal cortex and a decrease in myo-inositol in the posterior cingulate. The researchers described these findings as preliminary evidence of a possible mechanism. They did not establish Alzheimer’s prevention.
What does newer research show?
A more recent double-blind placebo-controlled pilot trial studied low-dose tesamorelin for 10 weeks in 22 participants whose cognition ranged from normal to mild cognitive impairment. This shows that the area is still being investigated, but the evidence base remains small and exploratory.
Good to know
“Peptide” describes a very broad family of molecules. Tesamorelin should not be grouped together with skincare peptides simply because both are called peptides. Different peptides can have completely different biological effects.
GlowOver40 Take
Interesting research? Yes. Proof that tesamorelin prevents Alzheimer’s disease? No. The responsible takeaway is that early clinical research has found signals relating to cognition and brain biology that deserve further study. Read the study — not just the headline.
Sources
Effects of growth hormone–releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults: results of a controlled trial
Archives of Neurology · 2012 · Peer-reviewed human study
pubmed.ncbi.nlm.nih.govGrowth hormone-releasing hormone effects on brain γ-aminobutyric acid levels in mild cognitive impairment and healthy aging
JAMA Neurology · 2013 · Peer-reviewed human study
pubmed.ncbi.nlm.nih.govThe effect of growth hormone-releasing hormone on cognition and brain connectivity in adults with cognition ranging from normal to mild cognitive impairment
eNeurologicalSci · 2026 · Peer-reviewed human study
pubmed.ncbi.nlm.nih.gov